August 2019 FDA Recall Drug by Epi Health, Llc
D-0120-2020 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Epi Health, Llc on August 26, 2019 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in Firm recalling only from EPI Field Representatives. and the recall is currently terminated.

Recall Number: D-0120-2020

Reason for Recall
Failed Dissolution Specifications:
Initiated
08-26-2019
Reported
10-02-2019
Quantity
1,626 5-count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Firm recalling only from EPI Field Representatives.
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.

Batch or Lot Expiration Information

Lot# T900093, Exp 11/2020